Atrasentan

14 interactions
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 11, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Letermovir Injection Gemfibrozil Ibrexafungerp Leniolisib Fostemsavir Mitapivat
14 Major
All (14) Major (14)

Major

Atrasentan Bempedoic Acid Nexletol Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Cyclosporine Injection Atopica Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Cyclosporine Ophthalmic Cequa Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Darolutamide Nubeqa Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Eluxadoline Viberzi Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Enasidenib Idhifa Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Encorafenib Braftovi Altered atrasentan exposure, reduced efficacy of atrasentan and an increased risk of atrasentan-related adverse reaction Details Atrasentan Fostemsavir Rukobia Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Gemfibrozil Lopid Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Ibrexafungerp Brexafemme Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Leniolisib Joenja Increased OATP1B1/OATP1B3 substrate exposure Details Atrasentan Letermovir Injection Prevymis Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Atrasentan Mitapivat Aqvesme Reduced atrasentan exposure and reduced efficacy of atrasentan Details Atrasentan Nafcillin Injection Unipen® Injection Reduced atrasentan exposure and reduced efficacy of atrasentan Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.